LT3134070T - Poliortoesterio ir organinės rūgšties užpildo kompozicijos - Google Patents
Poliortoesterio ir organinės rūgšties užpildo kompozicijosInfo
- Publication number
- LT3134070T LT3134070T LTEP15719954.8T LT15719954T LT3134070T LT 3134070 T LT3134070 T LT 3134070T LT 15719954 T LT15719954 T LT 15719954T LT 3134070 T LT3134070 T LT 3134070T
- Authority
- LT
- Lithuania
- Prior art keywords
- polyorthoester
- compositions
- organic acid
- acid excipient
- excipient
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
- A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461982300P | 2014-04-21 | 2014-04-21 | |
| PCT/US2015/026720 WO2015164283A1 (en) | 2014-04-21 | 2015-04-20 | Compositions of a polyorthoester and an organic acid excipient |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LT3134070T true LT3134070T (lt) | 2020-12-28 |
Family
ID=53039640
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LTEP15719954.8T LT3134070T (lt) | 2014-04-21 | 2015-04-20 | Poliortoesterio ir organinės rūgšties užpildo kompozicijos |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US10980886B2 (lt) |
| EP (2) | EP3134070B1 (lt) |
| JP (4) | JP6723162B2 (lt) |
| CY (1) | CY1123720T1 (lt) |
| DK (1) | DK3134070T3 (lt) |
| ES (1) | ES2837149T3 (lt) |
| HR (1) | HRP20202010T1 (lt) |
| HU (1) | HUE052224T2 (lt) |
| LT (1) | LT3134070T (lt) |
| PL (1) | PL3134070T3 (lt) |
| PT (1) | PT3134070T (lt) |
| RS (1) | RS61202B1 (lt) |
| SI (1) | SI3134070T1 (lt) |
| WO (1) | WO2015164283A1 (lt) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018048460A1 (en) | 2014-04-21 | 2018-03-15 | Heron Therapeutics, Inc. | A pharmaceutical composition comprising a delivery system, an amide-type local anesthetic, and meloxicam |
| HRP20211612T1 (hr) | 2014-04-21 | 2022-02-04 | Heron Therapeutics, Inc. | Polimerni sustavi za isporuku s dugim djelovanjem |
| EP3134070B1 (en) | 2014-04-21 | 2020-09-23 | Heron Therapeutics, Inc. | Compositions of a polyorthoester and an organic acid excipient |
| US9801945B2 (en) | 2014-04-21 | 2017-10-31 | Heron Therapeutics, Inc. | Long-acting polymeric delivery systems |
| JP2019514976A (ja) * | 2016-05-05 | 2019-06-06 | リクイディア・テクノロジーズ・インコーポレーテッド | 負荷と放出が正確に制御された術後疼痛用粒子 |
| WO2018122626A1 (en) * | 2016-12-26 | 2018-07-05 | Cellix Bio Private Limited | Compositions and methods for the treatment of chronic pain |
Family Cites Families (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4180646A (en) | 1975-01-28 | 1979-12-25 | Alza Corporation | Novel orthoester polymers and orthocarbonate polymers |
| US4093709A (en) | 1975-01-28 | 1978-06-06 | Alza Corporation | Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates) |
| US4131648A (en) | 1975-01-28 | 1978-12-26 | Alza Corporation | Structured orthoester and orthocarbonate drug delivery devices |
| US4079038A (en) | 1976-03-05 | 1978-03-14 | Alza Corporation | Poly(carbonates) |
| US4304767A (en) | 1980-05-15 | 1981-12-08 | Sri International | Polymers of di- (and higher functionality) ketene acetals and polyols |
| US4549010A (en) | 1984-06-27 | 1985-10-22 | Merck & Co., Inc. | Bioerodible poly(ortho ester) thermoplastic elastomer from diketene diacetal |
| US4780319A (en) * | 1985-07-08 | 1988-10-25 | Merck & Co., Inc. | Organic acids as catalysts for the erosion of polymers |
| US4957998A (en) | 1988-08-22 | 1990-09-18 | Pharmaceutical Delivery Systems, Inc. | Polymers containing acetal, carboxy-acetal, ortho ester and carboxyortho ester linkages |
| US4946931A (en) | 1989-06-14 | 1990-08-07 | Pharmaceutical Delivery Systems, Inc. | Polymers containing carboxy-ortho ester and ortho ester linkages |
| ES2149955T3 (es) | 1993-11-16 | 2000-11-16 | Skyepharma Inc | Vesiculas con liberacion controlada de sustancias activas. |
| US5968543A (en) | 1996-01-05 | 1999-10-19 | Advanced Polymer Systems, Inc. | Polymers with controlled physical state and bioerodibility |
| IT1283252B1 (it) | 1996-03-15 | 1998-04-16 | Pulitzer Italiana | Soluzioni di piroxicam iniettabili per via parenterale |
| EP1014946B1 (en) | 1997-09-18 | 2010-04-07 | Pacira Pharmaceuticals, Inc. | Sustained-release liposomal anesthetic compositions |
| GB9808720D0 (en) | 1998-04-23 | 1998-06-24 | Smithkline Beecham Biolog | Novel compounds |
| AU2001261516A1 (en) * | 2000-05-11 | 2001-11-20 | Advanced Polymer Systems Inc. | Semi-solid delivery vehicle and pharmaceutical compositions |
| US20050042194A1 (en) * | 2000-05-11 | 2005-02-24 | A.P. Pharma, Inc. | Semi-solid delivery vehicle and pharmaceutical compositions |
| US6613355B2 (en) | 2000-05-11 | 2003-09-02 | A.P. Pharma, Inc. | Semi-solid delivery vehicle and pharmaceutical compositions |
| US6590059B2 (en) | 2001-05-11 | 2003-07-08 | Ap Pharma, Inc. | Bioerodible polyorthoesters from dioxolane-based diketene acetals |
| DE10161077A1 (de) | 2001-12-12 | 2003-06-18 | Boehringer Ingelheim Vetmed | Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion |
| US6833139B1 (en) | 2002-01-09 | 2004-12-21 | Ferndale Laboratories, Inc. | Composition and method for the treatment of anorectal disorders |
| US20050019436A1 (en) | 2002-12-18 | 2005-01-27 | Algorx | Injectable capsaicin |
| EP1643968A1 (en) | 2003-05-30 | 2006-04-12 | ALZA Corporation | Implantable elastomeric depot compositions, uses thereof and method of manufacturing |
| US7666914B2 (en) | 2004-06-03 | 2010-02-23 | Richlin David M | Topical preparation and method for transdermal delivery and localization of therapeutic agents |
| ATE410408T1 (de) | 2004-07-12 | 2008-10-15 | Xenoport Inc | Von aminosäuren abgeleitete prodrugs von propofolzusammensetzungen und anwendungen davon |
| WO2006053175A2 (en) | 2004-11-10 | 2006-05-18 | Qlt Usa Inc. | A stabilized polymeric delivery system |
| CA2601762A1 (en) | 2005-02-03 | 2006-08-10 | Pfizer Products Inc. | Dosage forms providing controlled and immediate release of cholesteryl ester transfer protein inhibitors and immediate release of hmg-coa reductase inhibitors |
| US20070265329A1 (en) | 2006-05-12 | 2007-11-15 | Devang Shah T | Methods for the prevention of acute and delayed chemotherapy-induced nausea and vomiting (CINV) |
| US20070264338A1 (en) * | 2006-05-12 | 2007-11-15 | Shah Devang T | Base-stabilized polyorthoester formulations |
| US20070264339A1 (en) * | 2006-05-12 | 2007-11-15 | Ap Pharma, Inc. | Base-stabilized polyorthoester formulations |
| EP2044142A2 (en) | 2006-06-29 | 2009-04-08 | Medtronic, Inc. | Poly(orthoester) polymers, and methods of making and using same |
| US20090124952A1 (en) | 2007-11-09 | 2009-05-14 | Berman David A | Herpes Treatment and Dressing |
| US20100015049A1 (en) | 2008-07-16 | 2010-01-21 | Warsaw Orthopedic, Inc. | Methods and compositions for treating postoperative pain comprising nonsteroidal anti-inflammatory agents |
| US8119694B2 (en) | 2008-08-15 | 2012-02-21 | Arcion Therapeutics, Inc. | High concentration local anesthetic formulations |
| US20100203102A1 (en) | 2009-02-10 | 2010-08-12 | Warsaw Orthopedic, Inc. | Compositions and methods for treating post-operative pain using bupivacaine and an anti-onflammatory agent |
| WO2010138918A1 (en) | 2009-05-29 | 2010-12-02 | Pacira Pharmaceuticals, Inc. | Hyaluronidase as an adjuvant for increasing the injection volume and dispersion of large diameter synthetic membrane vesicles containing a therapeutic agent |
| US8410140B2 (en) | 2009-06-01 | 2013-04-02 | The Regents Of The University Of Michigan | Anesthetic methods and compositions |
| US20110033545A1 (en) | 2009-08-06 | 2011-02-10 | Absize, Inc. | Topical pharmaceutical preparations having both a nanoparticle solution and a nanoparticle suspension and methods for the treatment of acute and chronic pain therewith |
| GB2513267B (en) * | 2010-06-08 | 2015-03-18 | Rb Pharmaceuticals Ltd | Injectable flowable composition comprising buprenorphine |
| US9468599B2 (en) | 2011-12-27 | 2016-10-18 | Cmpd Licensing, Llc | Composition and method for compounded therapy |
| JP6454322B2 (ja) | 2013-03-15 | 2019-01-16 | ヘロン セラピューティクス， インコーポレイテッド | ポリオルトエステルおよび非プロトン性溶媒の組成物 |
| US9801945B2 (en) | 2014-04-21 | 2017-10-31 | Heron Therapeutics, Inc. | Long-acting polymeric delivery systems |
| HRP20211612T1 (hr) | 2014-04-21 | 2022-02-04 | Heron Therapeutics, Inc. | Polimerni sustavi za isporuku s dugim djelovanjem |
| EP3134070B1 (en) | 2014-04-21 | 2020-09-23 | Heron Therapeutics, Inc. | Compositions of a polyorthoester and an organic acid excipient |
| WO2018048460A1 (en) | 2014-04-21 | 2018-03-15 | Heron Therapeutics, Inc. | A pharmaceutical composition comprising a delivery system, an amide-type local anesthetic, and meloxicam |
-
2015
- 2015-04-20 EP EP15719954.8A patent/EP3134070B1/en active Active
- 2015-04-20 ES ES15719954T patent/ES2837149T3/es active Active
- 2015-04-20 WO PCT/US2015/026720 patent/WO2015164283A1/en active Application Filing
- 2015-04-20 SI SI201531456T patent/SI3134070T1/sl unknown
- 2015-04-20 DK DK15719954.8T patent/DK3134070T3/da active
- 2015-04-20 PT PT157199548T patent/PT3134070T/pt unknown
- 2015-04-20 RS RS20201530A patent/RS61202B1/sr unknown
- 2015-04-20 EP EP20190588.2A patent/EP3785700A1/en active Pending
- 2015-04-20 JP JP2016563469A patent/JP6723162B2/ja active Active
- 2015-04-20 LT LTEP15719954.8T patent/LT3134070T/lt unknown
- 2015-04-20 PL PL15719954T patent/PL3134070T3/pl unknown
- 2015-04-20 US US14/691,491 patent/US10980886B2/en active Active
- 2015-04-20 HU HUE15719954A patent/HUE052224T2/hu unknown
-
2019
- 2019-08-15 JP JP2019149028A patent/JP6977003B2/ja active Active
-
2020
- 2020-12-15 HR HRP20202010TT patent/HRP20202010T1/hr unknown
- 2020-12-15 CY CY20201101190T patent/CY1123720T1/el unknown
-
2021
- 2021-01-12 JP JP2021002583A patent/JP2021059598A/ja not_active Withdrawn
- 2021-03-22 US US17/209,078 patent/US11844837B2/en active Active
-
2022
- 2022-04-08 JP JP2022064460A patent/JP2022082776A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US10980886B2 (en) | 2021-04-20 |
| HUE052224T2 (hu) | 2021-04-28 |
| PT3134070T (pt) | 2020-12-21 |
| US11844837B2 (en) | 2023-12-19 |
| DK3134070T3 (da) | 2020-12-21 |
| CY1123720T1 (el) | 2022-03-24 |
| HRP20202010T1 (hr) | 2021-03-05 |
| SI3134070T1 (sl) | 2021-03-31 |
| EP3134070B1 (en) | 2020-09-23 |
| JP6723162B2 (ja) | 2020-07-15 |
| EP3785700A1 (en) | 2021-03-03 |
| JP2022082776A (ja) | 2022-06-02 |
| US20150297730A1 (en) | 2015-10-22 |
| RS61202B1 (sr) | 2021-01-29 |
| US20210205458A1 (en) | 2021-07-08 |
| JP2017513872A (ja) | 2017-06-01 |
| WO2015164283A1 (en) | 2015-10-29 |
| ES2837149T3 (es) | 2021-06-29 |
| JP6977003B2 (ja) | 2021-12-08 |
| EP3134070A1 (en) | 2017-03-01 |
| PL3134070T3 (pl) | 2021-07-05 |
| JP2019194267A (ja) | 2019-11-07 |
| JP2021059598A (ja) | 2021-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL246978A0 (en) | New paracetamol formulations | |
| GB201419579D0 (en) | Pharmaceutical compound | |
| EP3232781A4 (en) | Methods for forming peroxyformic acid and uses thereof | |
| GB201414730D0 (en) | Pharmaceutical compound | |
| GB201618482D0 (en) | Pharmaceutical compositions | |
| GB201419257D0 (en) | Pharmaceutical compositions | |
| GB201407934D0 (en) | Formulation | |
| IL249553A0 (en) | Pharmaceutical preparations | |
| SI3134070T1 (sl) | Sestave poliortoestra in pomožne snovi iz organske kisline | |
| HRP20181967T1 (hr) | Derivati aminoestera | |
| ZA201701492B (en) | Pyrazolothiazole compound and medicine | |
| IL250817A0 (en) | pharmaceutical preparations | |
| IL248835B (en) | A preparation of ciritinib | |
| GB201506755D0 (en) | Novel pharmaceutical formulation | |
| GB201407384D0 (en) | Formulation | |
| IL251362A0 (en) | formulation | |
| GB201417589D0 (en) | Pharmaceutical Formulations | |
| GB201402448D0 (en) | Novel formulation | |
| HUE048374T2 (hu) | Permetezhetõ fájdalomcsillapító készítmények | |
| GB201511301D0 (en) | Formulation | |
| IL251664A0 (en) | Inhalable formulation | |
| GB201407741D0 (en) | Novel drug formulation | |
| GB201419570D0 (en) | Pharmaceutical compound | |
| GB201400951D0 (en) | Novel drug formulation | |
| GB201411215D0 (en) | Pharmaceutical compound |